MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-05-0005074
Scotlin Pharmaceuticals Private Limited.
Scotlin Pharmaceuticals Private Limited. - trading in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹19.63 Lakh
▲ 5% YoY
Net profit · FY 2025
₹21,699
Net margin 1.1%
EBITDA · FY 2025
₹29,329
EBITDA margin 1.5%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Scotlin Pharmaceuticals Private Limited.
Data last updated:
Scotlin Pharmaceuticals Private Limited. is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 25 May 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2006PTC149188.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Hari Prakash Agarwal and Vishal Agarwal.
Its last annual general meeting (AGM) was held on 11 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at V – 441 Kh No. 37&38 Arvind Mohalla Ghonda Near Govt.Dispens, Ary, Delhi, India – 110053.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.63 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹21,699 (net margin 1.1%) and EBITDA of ₹29,329 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 1% over five years.
Scotlin Pharmaceuticals Private Limited. is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-05-0005074). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233DL2006PTC149188
Registration Number 149188
Incorporation Date 25 May 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 11 June 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-05-0005074
Recognitions & Rankings of Scotlin Pharmaceuticals Private Limited
Contact details
Scotlin Pharmaceuticals Private Limited.'s registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressV – 441 Kh No. 37&38 Arvind Mohalla Ghonda Near Govt.Dispens, Ary, Delhi, India – 110053
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Scotlin Pharmaceuticals Private Limited., buy the company report.
Comprehensive company report
Scotlin Pharmaceuticals Private Limited. - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Scotlin Pharmaceuticals Private Limited is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Scotlin Pharmaceuticals Private Limited., buy the company report.
Financials of Scotlin Pharmaceuticals Private Limited.
FY 2025 filings availableScotlin Pharmaceuticals Private Limited. reported revenue of ₹19.63 Lakh (up 5% YoY) for FY 2025.
Revenue · FY 2025
₹19.63 Lakh ▲ 5%
Net profit · FY 2025
₹21,699 margin 1.1%
EBITDA · FY 2025
₹29,329 margin 1.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 4%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 2%
5 years · compounded
▼ 6%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 5% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29,329 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21,699 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Scotlin Pharmaceuticals Private Limited., buy the company report.
Board of directors of Scotlin Pharmaceuticals Private Limited.
Scotlin Pharmaceuticals Private Limited has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hari Prakash Agarwal | Director | 31 May 2019 | 7 Years 5 Months | Current |
| Vishal Agarwal | Director | 30 Jun 2014 | 12 Years 4 Months | Current |
Peer comparison
Scotlin Pharmaceuticals Private Limited. is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bedrock Pharmaceuticals Private Limited | ₹19.71 Lakh (FY 2025) | 26.0% | Rudrapur, Uttarakhand, India | |||
| Alrosa Pharmaceuticals Private Limited | ₹19.64 Lakh (FY 2025) | -26.0% | Ambala, Haryana, India | |||
| Scotlin Pharmaceuticals Private Limited.this company | ₹19.63 Lakh (FY 2025) | ₹21,699 | 1.1% | 5.0% | Delhi, India | |
| Rashrinivas Pharmaceuticals Private Limited | ₹19.54 Lakh (FY 2024) | 35.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Scotlin Pharmaceuticals Private Limited., buy the company report.
Auditor
Scotlin Pharmaceuticals Private Limited. is audited by S. K. KUMAR & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S. K. KUMAR & CO | FY 2017 | 000204C |
Shareholding
The shareholding of Scotlin Pharmaceuticals Private Limited. is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Scotlin Pharmaceuticals Private Limited., buy the company report.
Legal cases
No court or tribunal cases involving Scotlin Pharmaceuticals Private Limited. are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Scotlin Pharmaceuticals Private Limited.; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Scotlin Pharmaceuticals Private Limited.; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Scotlin Pharmaceuticals Private Limited. has 6 board changes on record since 2009: 2 appointments and 4 cessations. The latest: Hari Prakash Agarwal ceased to be Additional Director on 12 Jul 2019.
AGM
Scotlin Pharmaceuticals Private Limited. last Annual general meeting of members was held on 11 Jun 2025 as per latest MCA records.
Filing
Scotlin Pharmaceuticals Private Limited. has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Hari Prakash Agarwal ceased to be Additional Director.
Appointed
Hari Prakash Agarwal was appointed as Director.
Ceased
Sanjeev Kumar Agarwal ceased to be Director.
Ceased
Deepak Tomar ceased to be Director.
Appointed
Vishal Agarwal was appointed as Director.
Ceased
Manish Srivastava ceased to be Director.
Incorporation
25 May 2006
Scotlin Pharmaceuticals Private Limited. was registered on 25 May 2006 with Roc Delhi & aged 20 years 5 months as per MCA records.
Frequently asked questions
Scotlin Pharmaceuticals Private Limited is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 25 May 2006 (20+ years old) and is registered under CIN U24233DL2006PTC149188.
Scotlin Pharmaceuticals Private Limited has 2 current directors:
- Hari Prakash Agarwal - Director
- Vishal Agarwal - Director
The latest financial statements of Scotlin Pharmaceuticals Private Limited on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 11 June 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Scotlin Pharmaceuticals Private Limited is U24233DL2006PTC149188. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scotlin Pharmaceuticals Private Limited was incorporated on 25 May 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Scotlin Pharmaceuticals Private Limited by revenue are Bedrock Pharmaceuticals Private Limited, Alrosa Pharmaceuticals Private Limited, Rashrinivas Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Hari Prakash Agarwal ceased to be Additional Director on 12 Jul 2019. Hari Prakash Agarwal was appointed as Director on 31 May 2019. Sanjeev Kumar Agarwal ceased to be Director on 31 May 2019. Scotlin Pharmaceuticals Private Limited has 6 board changes on record in total.
Yes, Scotlin Pharmaceuticals Private Limited is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-05-0005074).
The registered office of Scotlin Pharmaceuticals Private Limited is at V – 441 Kh No. 37&38 Arvind Mohalla Ghonda Near Govt.Dispens, Ary, Delhi, India – 110053.
Scotlin Pharmaceuticals Private Limited operates in the trading industry, in the other wholesale segment.
The compliance status of Scotlin Pharmaceuticals Private Limited is compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages